In PCa, extracellular FAs seem to be crucial contributors to lipid synthesis and tumor progression [69], and the inhibition of FA uptake by CD36 abrogation has been demonstrated to be an effective strategy to reduce tumor growth in preclinical models of PCa [70]. The gene discussed is CD36; the disease is posterior cortical atrophy.